Evidence map›Paper›PMID 3555103›Full record

ArticleThe American journal of pathology1987

Antigenic differences between human platelets and megakaryocytes.

P Hyde, D Zucker-Franklin

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA.Proceedings of the National Academy of Sciences of the United States of America · 1989
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

P Hyde
D Zucker-Franklin

Funding

ULTRASTRUCTURE OF LEUKOCYTES AND PLATELETSR01AM012274 · AM · NEW YORK UNIVERSITY · PI ZUCKER-FRANKLIN, DOROTHEA · 1985 to 1985
–
NIADDK NIH HHS AM 12274
6 · The paper itself

Abstract

To investigate the apparent paradox in the observation that most patients with immune thrombocytopenias have normal or increased numbers of megakaryocytes (MKs), the extent of antigenic cross-reactivity between normal platelets and MK was examined. Indirect immunofluorescence and ultrastructural studies were carried out by means of four antisera specific for platelets: anti-GpIb, anti-GpIIb/IIIa, anti-PLA1, and an antiserum from a patient with quinidine-induced thrombocytopenia. Following incubation of freshly collected marrow with these antisera, MK were first identified by phase-contrast microscopy and then inspected for fluorescence. Almost all MKs were found reactive with the last three antisera, albeit to a variable extent. In contrast, only 24% reacted with anti-GpIb. The pattern of fluorescence, ie, rim, partial or cytoplasmic, appeared to be related to the extent of MK fragmentation. Only rim fluorescence of living MKs could be interpreted to indicate that the platelet epitope was exposed on the surface of the precursor cell. The observations suggest that platelet antigens are variably expressed on the plasma membranes of MKs. In a clinical setting, the heterogeneity among platelet target antigens and the extent to which these are exposed on MKs at various stages of maturation may dictate the severity of the thrombocytopenia and degree of ineffective thrombocytopoiesis.

Indexed as

Antigens, Human PlateletAntigens, SurfaceBlood PlateletsFluorescent Antibody TechniqueHematopoiesisHumansIntegrin beta3IsoantigensMegakaryocytesPlatelet Membrane GlycoproteinsPurpura, ThrombocytopenicAntigens, Human PlateletAntigens, SurfaceIntegrin beta3IsoantigensITGB3 protein, humanPlatelet Membrane Glycoproteins

Identifiers

PMID3555103
PMCPMC1899752
OpenAlexW174881726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.